Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AALLON GROUP OYJ AALLON Apr 16, 2021 11.65 0.00   
 Admicom Oyj ADMCM Apr 16, 2021 96.70 +2.44   
 Afarak Group AFAGR Apr 16, 2021 0.22 0.00   
 Ahlstrom-Munksj÷ AM1 Apr 16, 2021 17.74 -0.11   
 Ahola Transport AHOLA Apr 16, 2021 1.74 0.00   
 Aktia Bank AKTIA Apr 16, 2021 10.36 +0.78   
 Alma Media ALMA Apr 16, 2021 10.06 +0.70   
 Altia ALTIA Apr 16, 2021 10.50 +1.35   
 Apetit APETIT Apr 16, 2021 13.20 -0.75   
 Aspo ASPO Apr 16, 2021 8.90 +0.23   
 Aspocomp Group ACG1V Apr 16, 2021 4.20 +1.94   
 Atria A ATRAV Apr 16, 2021 12.50 -0.16   
 Basware BAS1V Apr 16, 2021 39.00 +0.52   
 BBS-Bioactive Bone Substitutes BONEH Apr 16, 2021 3.53 +1.73   
 Bilot Plc BILOT Apr 16, 2021 8.50 +13.33   
 Biohit B BIOBV Apr 16, 2021 2.16 0.00   
 Bittium BITTI Apr 16, 2021 6.88 -1.29   
 Boreo Oyj BOREO Apr 16, 2021 49.30 +3.14   
 CapMan CAPMAN Apr 16, 2021 2.58 -0.77   
 Cargotec CGCBV Apr 16, 2021 47.40 +2.86   
 Caverion CAV1V Apr 16, 2021 5.58 +0.72   
 Citycon CTY1S Apr 16, 2021 7.30 -0.07   
 Componenta CTH1V Apr 16, 2021 4.01 +1.26   
 Consti Plc CONSTI Apr 16, 2021 13.60 -1.81   
 Detection Technology DETEC Apr 16, 2021 27.50 +2.23   
 Digia DIGIA Apr 16, 2021 8.02 -0.87   
 Digitalist Group DIGIGR Apr 16, 2021 0.05 -0.40   
 Dovre Group DOV1V Apr 16, 2021 0.41 +9.28   
 EAB Group EAB Apr 16, 2021 3.70 +3.06   
 Eezy Oyj EEZY Apr 16, 2021 5.60 -0.71   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK